Counterpoint Mutual Funds’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.59M Buy
+31,957
New +$6.64M 0.75% 23
2025
Q4
Sell
-17,251
Closed -$2.71M 374
2025
Q3
$2.71M Buy
17,251
+5,877
+52% +$908K 0.21% 33
2025
Q2
$1.91M Buy
+11,374
New +$1.69M 0.17% 46
2025
Q1
Sell
-9,226
Closed -$1.09M 299
2024
Q4
$1.09M Buy
9,226
+2,250
+32% +$263K 0.14% 48
2024
Q3
$771K Sell
6,976
-1,447
-17% -$151K 0.15% 55
2024
Q2
$828K Buy
8,423
+4,910
+140% +$500K 0.19% 35
2024
Q1
$393K Sell
3,513
-147
-4% -$15.9K 0.1% 54
2023
Q4
$369K Buy
3,660
+2,204
+151% +$219K 0.14% 17
2023
Q3
$126K Buy
+1,456
New +$132K 0.11% 150

Other funds holding CAH

Counterpoint Mutual Funds's CAH Position: Q2 2026 in Review

Counterpoint Mutual Funds opened a new position in Cardinal Health (CAH) in Q2 2026: 31,957 shares worth $7.59M. The stake represents 0.75% of the portfolio and ranks #23 among its holdings. This is a return to the name: Counterpoint Mutual Funds previously reported a position in CAH as recently as Q3 2025.

Counterpoint Mutual Funds first reported a position in CAH in Q3 2023 and has held it in 9 quarters since. 413 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Counterpoint Mutual Funds held 31,957 shares of Cardinal Health worth $7.59M as of Q2 2026.
  • Cardinal Health was a new Counterpoint Mutual Funds position in Q2 2026.
  • Cardinal Health made up 0.75% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #23 holding.
  • Counterpoint Mutual Funds first reported a position in Cardinal Health in Q3 2023 and has held it in 9 quarters since.
  • 413 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.